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ABSTRACT  Ten  monoclonal  antibodies  (My1-10)  against Dictyostelium  discoideum  myosin 
were  prepared and characterized.  Nine  bound  to the 210-kD  heavy chain and one (My8) 
bound to the 18-kD light chain. They defined six topographically distinct antigenic sites of the 
heavy chain. Five binding sites (the My1, My5, My10 site, and the My2, My3, My4, and My9 
sites) are located on the rod portion  of the myosin molecule. The position of the sixth site 
(the My6 and My7 site) is less certain, but it appears to be near the junction of the globular 
heads and the rod. Three of the antibodies (My2, My3, and My6) bound to myosin filaments 
in solution and could be sedimented in stoichiometric  amounts with the filamentous myosin. 
In  contrast, My4,  which  recognized  a  site on  the  rod,  inhibited  the  polymerization  of 
monomeric myosin into filaments. A single antibody (My6) affected the actin-activated ATPase 
of myosin. The nature of the effect depended on the valency of the antibody and the myosin. 
Bivalent IgG and F(ab')2 fragments of My6 inhibited the actin-activated ATPase of filamentous 
myosin by 50% whereas univalent Fab' fragments increased the activity  by 50%. The actin- 
activated ATPase activity of the soluble chymotryptic  fragment of myosin was increased 80- 
90% by both F(ab')2 and Fab' of My6. 
Dictyosteliurn serves as a model system for the investigation 
of many complex cellular processes (see reference 9  for re- 
view).  It is useful in the study of the molecular basis of cell 
motility because many complex cellular movements (such as 
pseudopod extension, phagocytosis, cytokinesis, and karyoki- 
nesis) which are typical of eukaryotic cells occur in amoebae 
of Dictyosteliurn. Several cytoskeletal proteins of Dictyoste- 
lium have been purified and characterized (see reference  18 
for  review).  Dictyostelium  myosin  (D.  myosin)  ~ was  first 
characterized by Clarke and Spudich (1) and is like skeletal 
muscle myosin in its structure and function. The molecule is 
composed of two heavy chains of 210 kD each and two each 
of two classes of light chains of 18 and  16 kD. The globular 
head region exhibits ATP-dissociable binding to actin and an 
actin-activated ATPase activity. The coiled-coil tail  region, 
called the rod,  is involved in the formation of filaments at 
low ionic strength. The 18-kD light chain and the rod portion 
of the heavy chain of D. myosin are phosphorylated in vivo 
(7,  16). Phosphorylation of the myosin heavy chain inhibits 
the formation of thick filaments in vitro (7). 
Monoclonal  antibodies that bind to different sites on D. 
'Abbreviations  used  in  this  paper."  D.  myosin,  Dictyosteliurn 
myosin; RAM, rabbit anti-mouse IgG; RIA, radioimmunoassay. 
myosin can 0rovide specific probes for studying the structural 
and functional properties of this myosin. Claviez et ai.  (2) 
used  electron  microscopy to  map the  binding  sites of five 
monoclonal antibodies against D. myosin. All five bind to the 
rod. The preparation and characterization of ten additional 
anti-myosin monoclonal antibodies,  one of which binds to 
the  18-kD light chain, is presented here. Their effects on the 
assembly of myosin and  its actin-activated ATPase is  dis- 
cussed. An accompanying paper by Hicker et al. (3) describes 
the positions of the antigenic determinants as visualized by 
electron microscopy and the effects of the antibodies on in 
vitro myosin-mediated motility. 
MATERIALS AND  METHODS 
Myosin and Actin:  RNA-free myosin was isolated and purified from 
Dictyostelium discoideum strain Ax-3 as previously described (11) with minor 
modifications (Griffith, L. M., and J. A. Spudich, manuscript  in preparation). 
The chymotryptic  soluble fragment of D. myosin was prepared  as previously 
described (16). Actin  was purified  from  rabbit  skeletal muscle  (19). Rabbit 
skeletal muscle myosin was purified by the procedure of  Kielley and Harrington 
(5). Acanthamoeba myosin and turkey gizzard myosin were gifts from Dr. D. 
Kiehart  (The  Johns Hopkins  University)  and  Dr.  Z.  Cande  (University  of 
California at Berkeley), respectively. 
Monoclonal Antibody  Production:  Production  of hybridomas 
was according to the method  of Parham  (12). BALB/c mice received three 
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adjuvant at 3-wk intervals. The first immunization was with complete adjuvant 
and the other two were with incomplete adjuvant.  1 wk after the third immu- 
nization,  plasma  was tested  for antibody  binding  to purified D.  myosin  by 
solid-phase radioimmunoassay  (RIA). Specific binding at titers of 1/625 was 
obtained. Three mice were selected and each received one intravenous injection 
of 20 ug of  D. myosin in phosphate-buffered saline (PBS) (Gibeo Laboratories, 
Grand Island, NY) per day for 4 d prior to fusion. Spleen cells were fused to 
the myeloma  cell line, Sp2/0-Agl4  (17). Hybridomas  were screened for pro- 
duction  of antibodies  binding  to  purified  D.  myosin  by  solid-phase  RIA. 
Hybridomas  were cloned by fluorescence-activated cell sorting and then pas- 
saged as ascites tumors in BALB/c mice. 50-200 ml ofascites fluid was obtained 
for each  and the immunoglobulin  was purified according to procedures  de- 
scribed by Parham et al. (14). 
Solid-phase  RIA:  All assays were performed  in Dynatech  microtiter 
plates (Dynatech  Precision Sampling Corp.,  Baton Rouge, LA) at 23"C. PBS 
with 0.5% bovine serum albumin (BSA) (Sigma Chemical Co., St. Louis, MO) 
was the assay buffer used for dilutions  and washing. Proteins were iodinated 
using chloramine-T  (4,  10). 
25 ul of myosin (5-10 mg/ml) in PBS was placed in a well of a microtiter 
plate for 2-4 h. After washing the wells three times and incubating them with 
assay buffer for 0.5 h, 25 ~1 of the monoclonal antibody solution was added for 
1-2  h. The wells were then  washed three  times,  and  25 ul of 1251-F(ab')2 of 
rabbit anti-mouse  lgG (RAM) containing  250,000 cpm was added. After 1 h, 
the  wells were again  washed  three  times  before separation  with  a  hot-wire 
cutting  device.  3`-Counting for bound  radioactivity  was  performed  using a 
Beckman  3,-4000 (Beckman  Instruments, Inc., Palo Alto, CA). The  level of 
nonspecific binding was determined  by counting  microtiter plate wells coated 
with BSA and wells coated with myosin incubated  with a nonspecific control 
antibody of the same isotype, X63 (6). 
Blocking studies  were  performed  by  adding  12.5 izl  of the  appropriate 
dilution of unlabeled blocking antibody to a myosin-coated microtiter well for 
45 min. Then  12.5 ul of ~2~l-labeled antibody  was added  for an additional  30 
min.  The supernatant was removed  without  addition  of assay buffer before 
washing three times with assay buffer and 3`-counting. 
Isotype  Determination:  Determination  of the isotype of antibodies 
was performed  by solid-phase RIA as described above  using affinity-purified 
goat antibodies  that are specific for binding to mouse IgG ofisotype lgGl or 
IgG2 as iodinated  second step reagents (15). For each of the  10 monoclonal 
anti-myosin antibodies the amount of iodinated anti-lgG1  bound was 80% or 
more of  the amount ofiodinated  RAM bound, whereas the amount ofiodinated 
anti-lgG2 bound was similar to the amount of binding in microwells containing 
nonspecific control lgG. 
PAGE and Immunoblotting:  SDS  PAGE was carried  out as de- 
scribed (8). Slab gels were scanned with a Transidyne RFT scanning densitom- 
eter  (Transidyne  General  Corp.,  Ann  Arbor,  MI) at  600  nm.  The relative 
amount of protein present in a single band was quantitated  by cutting out and 
weighing the corresponding peak. The absolute amount of protein present was 
determined  by  comparing  the  weight  of a  peak  with  the  weight  of peaks 
generated from electrophoresis of known amounts of the same protein. 
Immunoblotting was performed according to Towbin et al. (20). After SDS 
PAGE,  proteins  were electrophoresed  out of the gel and onto nitrocellulose 
paper. The nitrocellulose paper was incubated in a 3% BSA solution to saturate 
protein-binding  sites. Then the nitrocellulose papers were placed in a solution 
containing  10 ~g/ml of the monoclonal  antibody,  5% heat-inactivated  rabbit 
serum,  3%  BSA, 0.02% SDS and 0.2-1.0%  Triton X-100. After a series of 
washings, the nitrocellulose papers were placed in solutions containing  5 x  l0  s 
cpm 1251-RAM/ml. Subsequently, the nitrocellulose papers underwent another 
series of washings and were dried  prior to autoradiography  using Kodak  X- 
Omat X-Ray  film with a  Dupont Cronex  Intensifying screen (DuPont Co., 
Wilmington, DE). 
Sedimentation Assays:  Binding to myosin filaments was tested by 
incubating  12 ~zg myosin and 14.4 ug IgG in 150 ul of 25 mM PIPES (pH 6.8), 
5 mM MgCI2, 0. I mM CaCI:, and 15 mM KCI at 23*C for 30 min. The samples 
were then centrifuged in a Beckman airfuge (Beckman Instruments,  Inc,) at 17 
pounds per square inch (psi) for 17 rain. The pelleted material was resuspended 
in 30 ul of buffer for SDS PAGE and densitometric quantitation.  As a control, 
the  same  volume  of buffered solution  containing  either  myosin or antibody 
alone was centrifuged at the same time.  For the three monoclonal  antibodies 
that bound to filamentous myosin, additional sedimentation  experiments were 
performed under the same conditions  except the amount of immunoglobulin 
added was changed or 25 ug of actin was added to the reaction mixture. 
Sedimentations  with the soluble fragment olD. myosin were performed in 
100 ul of solution containing 3 ug of soluble fragment, 7 ug of antibody, 25 tzg 
of actin, and the same buffer as above. The samples were incubated at 23"C for 
30  rain  and  then centrifuged  in a  Beckman airfuge (Beckman  Instruments, 
Inc.) at 8 psi for 10 min to pellet the F-actin with its associated proteins. The 
pelleted material was resuspended in 30 ul of buffer prior to SDS PAGE and 
densitometric quantitation. 
To examine  the  inhibition  of filament  formation,  we performed  sedimen- 
tation assays by incubating  14.2 ug oflgG with 12 ug of myosin in 15 ul of 0.5 
M KCI, 10 mM PIPES (pH 6.8),  1 mM dithiothreitol,  and  1 mM EDTA for 
40 rain at 23°C. The solution was then diluted  10-fold with buffer containing 
20 mM PIPES (pH 6.8), 5 mM MgCI~, and 1 mM CaCI2, and then incubated 
for 20  min to allow  filaments  to form.  The samples  were centrifuged  in  a 
Beckman airfuge (Beckman Instruments,  Inc.), and  the pelleted material was 
resuspended in 30 ul of buffer prior to SDS PAGE and densitometric  quanti- 
ration. The amount of myosin heavy chain sedimenting in the presence of lgG 
is expressed as a percentage of the amount sedimenting in the absence of lgG. 
ATPase Assay:  ATPase activity was measured  using [3`32p] ATP, as 
described (1). The assay was in  100 ~1 of solution  containing  25  mM PIPES 
(pH 6.8), 5 mM MgCI2, 0.1  mM CaCI2, 15 mM KCI, I mM ATP, either 6/ag 
of myosin or 1-3 ug of soluble fragment, and the indicated amount of actin or 
monoclonal  antibody.  The solutions  were incubated  at 25"C for  15-20 min. 
The aetin-activated  ATPase activity was calculated by subtracting the activity 
found for myosin or soluble fragment alone (2-5 % of  the actin-activated activity 
with excess actin). 
Preparation of F(ab')2and Fab' Fragments of My6:  Antibody 
fragments were made from My6 lgG as described (13). IgG was digested with 
pepsin (25 ~g/ml) in 0.1 M citrate (pH 3.5) for 12 h at 37"C to produce F(ab')2. 
The reaction  was stopped  by addition of l  M  Tris-HCI (pH  8.0) to a final 
concentration  of 0.2  M.  L-cysteine  was  added  to  one-half of the  F(ab')2 
preparation  to a  concentration  of 15  mM,  and  incubated  at  37°C for 4  h. 
Iodoacetamide was then added to a concentration  of 30 mM and incubated for 
12  h at 4"C to produce  Fab'. The Fab' and F(ab')2 preparations  were then 
dialyzed against  10 mM KCI, 5 mM Tris-HCI (pH 7.5). 
RESULTS 
Monoclonal Anti-Dictyostelium  Myosin 
Ten hybridomas (Myl-10) which secrete  IgGl  antibodies 
against myosin were produced. They were passaged as ascites 
tumors  and  the  immunoglobulin  purified  from  the ascitic 
fluid by sequential ammonium sulfate fractionation, Sepha- 
dex G-200, and DEAE column chromatography (14). 
Indirect  solid-phase  RIA  showed  that  Myl-10  bind  to 
purified D. myosin (Fig.  1). All except My7 and My8, which 
appear to have a lower affinity for myosin, exhibited a plateau 
of binding extending to immunoglobulin concentrations of 1 
ug/ml  (Fig.  1).  The  antibodies  bound  poorly  to  myosins 
purified from other cells (Fig. 2). The strongest cross-reaction 
was seen with My4 binding to smooth muscle myosin. Even 
in this case  more than  100 ug/ml  of My4 was required  to 
bind an amount of radioactivity equivalent to that bound to 
D. myosin with a  1,000-fold lower antibody concentration. 
Localization of the Sites ot Antibody Binding by 
Immunoblotting 
We used immunoblotting to determine to which subunit of 
D.  myosin the monoclonal antibodies bind. Nine antibodies 
bound to the 210-kD heavy chain (Fig. 3), and one antibody, 
My8, bound to the  18-kD light chain (Fig.  4). None bound 
to the  16-kD light chain. When tested against a crude cyto- 
plasmic extract of Dictyostelium,  all nine antibodies bound 
specifically to a polypeptide that co-migrated with the appro- 
priate  subunit of purified D.  myosin. In addition, My4 and 
My5  bound to a  35-kD  protein  in the cytoplasmic extract 
that may be a fragment of the myosin heavy chain. 
We  used immunoblotting to further  localize the binding 
sites of the nine antibodies against the heavy chain. Chymo- 
trypsin  cleaves  D.  myosin  into  a  soluble,  globular,  NHz- 
terminal head fragment  (soluble fragment),  and into a  fila- 
mentous, COOH-terminal tail fragment, both of which mi- 
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FIGURE  I  Titration of My1-10 against D. 
myosin in solid-phase RIA (My1-5 are in A; 
My6-10  in  B;  control  IgG  was  X63). The 
concentration on the abscissa is that of the 
monoclonal antibody in the first incubation 
of the assay. The bar  in the  bottom right 
hand  corner  of  each  panel  indicates  the 
range of values obtained when the highest 
concentration of  monoclonal IgG  was  in- 
cubated in microtiter wells coated with BSA. 
grate as 105-kD on denaturing gels (16). These fragments were 
made, separated by ultracentrifugation and tested for binding 
with the antibodies. Seven of the antibodies, Myl-5, My9, 
and Myl0, bound to the sedimentable tail fragment (Fig. 5). 
My6 and My7 bound to both the soluble fragment and the 
tail fragment. The relative intensities of the autoradiographic 
signals  indicated  that  My6  and  My7  bind  to  the  soluble 
fragment to a greater extent than to the tail fragment. Electron 
microscopy of these fragments described by Flicker et al. in 
this issue (3) showed heterogeneity in the fragment prepara- 
tions and binding of My6 to a position on the rod close to 
the globular heads.  Thus,  heterogeneity in  the  position of 
chymotryptic  cleavage probably explains why My6 reacts with 
both the soluble fragment and the tail fragment preparations. 
Similar analysis  was  not  possible  with  My7.  However the 
blocking analysis described below indicates they are directed 
against a closely related site. 
Blocking Experiments Reveal Seven Distinct 
Antibody Binding Sites on Myosin 
Antibodies that bind to topographically related sites on the 
myosin molecule were identified by competition experiments 
(Fig.  6). If an unlabeled monoclonal antibody prevents the 
binding of another iodinated antibody to myosin, this indi- 
cates the binding of  antibodies to sites on the myosin molecule 
that are close to each other. No blocking indicates the sites 
are topographically distinct. Eight of the antimyosin antibod- 
ies were iodinated and shown to retain their immunological 
specificity.  Unlabeled Myl,  MyS,  and  Myl0 inhibited the 
binding of iodinated My 1 to the same extent, which indicates 
that they bind to related sites. In fact, the binding sites of all 
three antibodies are indistinguishable by direct visualization 
in the electron microscope, as shown by Flicker et al. (3). The 
binding of iodinated My7 was  inhibited by unlabeled My6 
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FLGURE 2  Binding of monoclonal antibodies made against D. myosin to myosins from other species. Results are of solid-phase 
RIA with (A) rabbit skeletal muscle, (B) turkey gizzard, and (C) Acanthamoeba  myosins. 
1018  THE  JOURNAL  OF  CELL  BIOLOGY  '  VOLUME  100,  1985 FIGURE 3  Immunoblots demonstrating the binding of nine monoclonal anti-myosin antibodies to the 210-kD D. myosin heavy 
chain. The GEL shows 10% SDS PAGE of (a) 2.5 #g of purified D. myosin, (b) 5 #l of a Dictyostelium  cytoplasmic  extract, and (c) 
protein standards. The BLOT shows nitrocellulose paper stained with Amido black after electrophoretic transfer of the GEL. Note 
that the myosin  heavy chain transfers poorly. The AUTORADIOGRAMS are of nitrocellulose papers after incubation with the 
various My antibodies, indicated by their number, or (C) the control IgG and subsequent incubation with 12SI-RAM. 
FIGURE 4  Immunoblot demonstrating the binding of My8 IgG to the 18-kD light chain of D. myosin. The GEL is 15% SDS PAGE 
of (a) protein standards, (b) 5 #1 of a Dictyostelium  cytoplasmic extract,  (c) 3 #g of purified D. myosin, and (d) 4 #g of purified 
My1  IgG. The BLOT is nitrocellulose paper stained with Amido black after electrophoretic transfer of the GEL. The AUTORADf- 
OGRAMS are of nitrocellulose papers after incubation with either My8 (8) or control IgG (C) and subsequent  incubation with a 
solution containing 12SI-RAM. 
but the binding of iodinated My6 was not inhibited by unla- 
beled My7. Thus My6 and My7 may identify closely related 
sites. The binding of the other heavy chain antibodies and the 
light chain antibody were not inhibited by any other antibody. 
These results show that these antibodies define a  minimum 
of  seven distinct antigenic sites on the myosin molecule (Table 
I). 
My2, My3, and My6 Bind and Sediment with 
Myosin Filaments 
The ability of the antibodies to bind to filamentous myosin 
was tested by sedimenting myosin plus antibody at low ionic 
strength. Under  these  conditions  D.  myosin  forms bipolar 
filaments similar to those formed by skeletal muscle myosin 
PELTZ  ET AL.  Monoclonal Anti-myosin Antibodies  1019 FIGURE  5  Immunoblot localization of the binding of monoclonal anti-myosin IgGs to chymotryptic fragments  of D. myosin. The 
GEL is 10% SDS PAGE of (a) protein standards, (b) 2 ~,g of protein sedimenting after chymotryptic cleavage of purified D. myosin, 
and (c) 2 ~g of protein that remains in solution after centrifugation of chymotryptic cleavage products of D. myosin.  The BLOT is 
nitrocellulose paper stained with Amido black after electrophoretic transfer of the GEL. AUTORADIOCRAMS are of nitrocellulose 
papers after incubation with the My antibodies indicated by number or control IgG (C) and subsequent incubation with a solution 
containing ~2SI-RAM. 
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FIGURE  6  Solid-phase  blocking  RIA to identify antibodies that  bind  to spatially related sites on D. myosin.  Representative results 
to show the  blocking  of 12SI-My1  (A),  12SI-My6  (B),  and  ~2SI-My7  (C) binding  to D.  myosin  are shown.  Blocking antibodies  are as 
shown  in A. The bar indicates the amount  of binding  in the absence of blocking  Ig. 
TABLE  I 
Identification  of Monoclonal Anti-myosin Antibodies Binding to Spatially Related Sites on Dictyostelium  Myosin 
Blocking IgG 
Iodinated IgG  My1  My2  My3  My4  My5  My6  My7  My8  My9  My10 
My1  +  -  -  -  +  ....  + 
My2  -  +  ........ 
My3  -  -  +  ....... 
My4  -  -  -  +  ...... 
My6  .....  +  .... 
My7  .....  +  +  -  -  - 
My8  .......  +  -  - 
My9  ........  + 
Summary of solid-phase  blocking  RIA to identify  monoclona[  anti-myosin  antibodies  binding  to spatially  related sites on  Dictyostelium  myosin.  (+)  Indicates 
that the binding of the iodinated antibody was inhibited  to background  levels when the blocking antibody concentration was above  1 pg/ml.  (-)  Indicates the 
binding of the iodinated antibody  to Dictyostelium  myosin was not inhibited  by the presence of the unlabeled  blocking antibody. 
in vitro (I). (In this paper, the term myosin filaments refers 
to those filaments formed in vitro by dilution of a D. myosin 
solution  to  low ionic  strength.)  Myl,  My4,  My5,  My7-10, 
and control lgG did not co-sediment with myosin filaments 
whereas My2, My3, and My6 did (Fig. 7). The stoichiometries 
of the binding of the three monoclonal antibodies were 1 tool 
My2 per 2  mol myosin and  l  tool My3 or My6 per  1 mol 
myosin (Table II). This ratio did not change when the molar 
ratio oflgG to myosin in the starting solution was varied, nor 
did the binding of myosin to actin interfere with the binding 
of the monocional lgG (Fig.  8). 
Of the  antibodies  that  bind  and  sediment  with  myosin 
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The third antibody, My6, preferentially bound to the soluble 
fragment in immunoblotting but also showed some binding 
to the tail fragment. The soluble fragment of D.  myosin is 
known  to  bind  to  actin  filaments  in  an  ATP-dissociable 
fashion and  will  sediment with actin filaments (16).  When 
My6 was added to this system, it too sedimented with actin 
filaments, but only if  the head fragment of  myosin was present 
(Fig.  9).  When binding of the head fragment to  actin  was 
inhibited with ATP, co-sedimentation of My6 with the actin 
FIGURE  7  10% SDS PAGE analysis of sedimentation assay for the 
binding of monoclonal anti-myosin antibodies to  filamentous D. 
myosin in solution. Antibody was incubated with myosin filaments 
which were then centrifuged. The pellet was resuspended in 30 pl 
of buffer and 15 pl analyzed by SDS PAGE. Lanes show the pelleted 
material from  solutions containing: (M)  myosin  without  IgG; (C) 
myosin and control IgG; (K) myosin in solution contain 0.5 M  KCl; 
and (1-10) Myl-10, respectively. 
FIGURE 8  10% SDS PAGE analysis of sedimentation assay to de- 
termine the stoichiometry of My6 binding to filamentous D. myosin 
(12 pg) in solution. Sedimentation assays were with  (f)  3.6 pg of 
My6, (g) 7.2 pg of My6, (h)  14.4 pg of My6, or (i) 7.2 pg of My6 
with 25 pg of actin. Centrifugation of solutions containing (a) 7.2 pg 
My6, (b) 7.2 pg control Ig, or (c) 7.2 pg of My6 plus 25 #g of actin 
does not result  in  sedimentation of antibodies. Pelleted  material 
from  solutions  containing (d)  myosin,  (e)  myosin  and  7.2  pg  of 
control Ig, and (j)  myosin  plus 0.5  M  KCI are also shown.  MHC, 
Myosin heavy chain; IgHC,  IgG heavy chain; IgLC, IgG light chain. 
TABLE  II 
Stoichiometry  of Anti-myosin Monoclonal Antibody Binding  to 
Dictyostelium Myosin or Its Soluble Chymotryptic Fragment 
Native myosin  Observed Ratio:  Indicated Ratio: 
('pg MHC  1  /'  mol IgG 
IgG  \~J  \tool myosinJ 
My2 (7)  7.25 _+ 1.84  1/2 
My3 (5)  3.67 _+ 0.47  1/1 
My6 (4)  3.96 + 0.34  1/1 
Soluble Chymo- 
tryptic Fragment 
Observed Ratio: 
(pg Fragment  HC)pg  IgHC 
Indicated Ratio: 
(molm°llgG  HC)  fragment 
My6 (3)  2.35 + 0.35  1/2 
Summary  of densitometric  quantitation  of sedimentation  assays  to determine 
the stoichiometry  of monoclonal  anti-myosin  antibodies  binding to Dictyos- 
telium myosin  or the soluble  chymotryptic  fragment  in solution.  Sedimenta- 
tion assays  were performed  as described  in the legend  to Figs. 7 and 8. The 
lanes  were  scanned  with a densitometer  and the amount  of protein  in a peak 
was determined  by comparison  with standards  as described  in Materials  and 
Methods. The molar ratio of IgG to the heavy  chain  of native  myosin  or the 
soluble  chymotryptic  fragments  was then determined.  The ratio did not vary 
with the ratio of IgG to myosin initially present in solution, nor did the 
addition of actin alter the ratios for native myosin. The ratios remained 
constant for the number  of different  determinations  indicated  in parentheses. 
FIGURE 9  10% SDS PAGE of sedimentation  assay  to determine  the 
stoichiometry of My6 binding to the chymotrypic soluble fragment 
of D.  myosin.  Sedimentation assays contained 3 #g myosin  frag- 
ment, 7.2 pg antibody, and 25 pg of actin.  Lanes show the pellet 
after centrifugation of solutions  containing: (a)  My6;  (b)  myosin 
fragment and actin; (c) control IgG and actin; (d) control IgG, actin, 
and myosin fragment; (e) My6 and actin; (f) My6, actin, and myosin 
fragment; and (g) My6, actin, myosin fragment, and 1 mM ATP. The 
heavy and light chains of My6 are indicated by IgHC and IgLC. 
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Effect of Monoclonal Anti-myosin Antibodies on the Formation 
of Filaments by Dictyostelium Myosin 
IgG  % Filaments Sedimenting 
X63  95 ±  1 
My1  89 ±  3 
My2  121  ±  17 
My3  116 ±  15 
My4  21 ±  7 
My9  99 ±  13 
Effect  of  monoclonal  anti-myosin  IgG  on  the  formation  of  filaments  by 
Dictyostelium myosin. Solutions containing 4 mol  of IgG  per mol  of myosin 
and 0.5 M  KCI were incubated for 40 min  before dilution  to lower the salt 
concentration  to allow filaments  to form.  The amount of filaments formed 
was  determined  by sedimentation  as described  in  Materials and Methods. 
The values are recorded as a percentage of the amount of myosin filaments 
sedimenting from a control solution that did not contain any IgG. All values 
are the average of three determinations. 
TABLE IV 
Effect of Monoclonal Anti-myosin Antibodies on the Actin-acti- 
vated ATPase Activity of Native Dictyostelium Myosin 
Mean%con- 
IgG  trol  Range 
ControllgG  100  96-100 
My1  98  97-100 
My2  96  89-100 
My3  93  82-100 
My4  88  86-95 
My5  85  73-95 
My6  50  42-62 
My7  80  75-100 
My8  83  73-97 
My9  95  89-100 
My10  77  70-100 
Effect of monoclonal anti-myosin IgG on the actin-activaled ATPase activity 
of Dictyostelium myosin. All ATPase activities were determined as described 
in Materials  and Methods in the presence of 4 tool of IgG per mol of myosin. 
The control  value was the actin-activated  ATPase activity of a sample  con- 
taining myosin without any added IgG. The data summarized in this table are 
the averages of 4 to 6 duplicate determinations. 
filaments was  also eliminated. The amount of control IgG 
sedimenting with  actin  filaments  was  independent  of the 
presence of the myosin head fragment (Fig. 9). The stoichi- 
ometry of binding of My6 to the soluble fragment of myosin 
was 1 mol IgG per 2 mol soluble fragment heavy chain (Table 
II). 
My4 Inhibits Filament Formation 
Antibodies that bind to five different sites on the myosin 
rod were tested for their effect on filament formation. They 
were incubated with monomeric myosin in high salt and then 
diluted to lower the salt concentration and to allow filaments 
to form. Filament formation was quantitated by sedimenta- 
tion. My4 inhibited filament formation by 80%, in contrast 
to My l and My9 which had no effect. My2 and My3, which 
co-sediment with myosin filaments, caused a slight increase 
in the amount of sedimented myosin (Table Ill). 
My6 Alters the Actin-activated A TPase of Myosin 
Nine of  the antibodies had little effect on the actin-activated 
ATPase activity of myosin in solution (Table IV). My6 inhib- 
ited the activity by -50% (Table IV). To further investigate 
the effect of  My6 on the ATPase activity, we prepared bivalent 
F(ab')2 and monovalent Fab' fragments of My6. Over a range 
of actin concentrations, My6-F(ab')2 inhibited the ATPase 
activity of myosin by -50%  as seen with the IgG, whereas 
My6-Fab'  increased the activity by -50%  (Fig.  10). These 
effects were observed at ratios of 1 tool of F(ab')2 added per 
mol of myosin and 2 mol of Fab' added per mol of myosin. 
To eliminate effects due to the formation of myosin filaments, 
we  determined the  actin-activated ATPase  activity of the 
soluble  fragment  of myosin  in  the  presence  of the  My6 
fragments.  Under  these  conditions F(ab')2  and  Fab'  both 
increased the  actin-activated ATPase activity by  80-150% 
above control values over a range ofactin concentrations (Fig. 
10). Control IgG had no effect on the actin-activated ATPase 
activities of either myosin or the soluble fragment of myosin. 
Monovalent and bivalent fragments of My6 did not alter the 
ATPase activity of myosin or the  soluble fragment in the 
absence of actin. 
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FIGURE 10  Effect of monovalent (Fab') 
and bivalent F(ab')2 fragments of My6 on 
the actin-activated ATPase of D. myosin 
or of the soluble chymotryptic fragment. 
(A) 6 ~g of myosin, the indicated actin 
concentration and either (A) no IgG, (A) 
1.4  /~g  control  IgG;  (O)  1.3  ~,g  My6 
F(ab')2, or (0)  1.3 ~g My6  Fab'. (B)  1.5 
#g  soluble  chymotryptic  myosin  frag- 
ment, the indicated amount of actin, and 
either (O) no IgG, (Q) 1.0 #g control IgG, 
(I-2) 0.5 ~,g My6 F(ab')2, or (11) 0.5 ~,g My6 
Fab'. The solutions were incubated for 
1 h before the measurement  of the actin- 
activated ATPase activity. Each point is 
the average of two determinations. Dif- 
ferences  in the ATPase activities at the 
same actin concentration on a per active 
site basis of chymotryptic fragment ver- 
sus myosin reflect the greater affinity of 
native myosin for actin than that of chy- 
motryptic fragment (16). DISCUSSION 
D.  myosin  is  composed  of two  structural  and  functional 
domains that  can  be separated by limited proteolysis. The 
carboxy-terminal tail domain is a coiled-coil involved in the 
assembly of myosin into filaments. The amino-terminal do- 
main consists of the globular heads, which are involved in 
actin and nucleotide binding, plus a small part of the rod-like 
tail (3). Ten monoclonal antibodies were obtained that bind 
strongly to  D.  myosin  and  weakly to  other  myosins.  The 
antibodies define seven distinct antigenic sites on D. myosin: 
one on the 18-kD light chain, one on the amino-terminal half 
of the heavy chain, and five on the carboxy-terminal half of 
the heavy chain.  My6 and My7 show strong binding to the 
globular amino portion of the heavy chain and a weaker but 
significant binding to a  105-kD band in the pelletable mate- 
rial.  This result with My6 and My7 may be explained in the 
following ways. Topographic mapping and  electron micro- 
scopic analysis of My6-myosin complexes described in  the 
following paper (3)  show that  the  site  recognized by these 
antibodies is in the region at which proteolytic cleavage takes 
place. Heterogeneity of proteolysis could lead to mostly head 
and some tail fragments having the My6 and My7 sites or, 
alternatively, the antigenic sites might be split by a  unique 
chymotrypsin  cleavage  yielding  fragments  that  both  have 
affinity for the antibodies. 
Although  the  monoclonal antibodies all bind strongly to 
myosin immobilized on the surface of a  microtiter well  or 
nitrocellulose paper,  only three  of the ten,  My2,  My3  and 
My6, co-sediment with myosin filaments. Since the stoichi- 
ometry of antibody binding is  not  altered when  myosin is 
bound  to  actin,  these  antibodies  and  actin  must  bind  to 
spatially distinct  sites on  the  myosin molecule.  Antibodies 
against  three  distinct  sites  on  the  carb0xy  portion  of the 
myosin heavy chain  do  not co-sediment with  myosin fila- 
ments. These antibodies may have low affinity for myosin or 
the site to which they bind on monomeric myosin may not 
be accessible when myosin filaments are formed. My6 and 
My7 bind to a spatially related site on the myosin molecule, 
yet My6 co-sediments with myosin filaments and My7 does 
not. It is most likely that this difference is because the affinity 
of My7  is much less  than that  of My6. The nonreciprocal 
blocking between My6 and My7 in the solid-phase blocking 
RIAs supports this interpretation. 
My4 inhibits filament formation indicating that the site it 
recognizes on the tail of the myosin heavy chain is in a region 
essential for that process.  My2 and  My3  slightly enhanced 
filament  formation;  this  may be  a  result  of the  antibody 
providing additional cross-linking of myosin filaments. 
Nine  of the  antibodies  did  not  alter  the  actin-activated 
ATPase activity of myosin. In the cases of My2 and My3, in 
which binding to myosin in solution is apparent by sedimen- 
tation, we can conclude that binding does not alter the actin- 
activated ATPase activity. In the other cases, the binding in 
solution  may simply be too weak to have an effect on the 
ATPase activity. The inhibition by My6 could be due to the 
formation of a large aggregate that is less accessible to actin 
filaments or a conformational constraint imposed on myosin 
by bivalent antibody binding.  When  cross-linking is elimi- 
nated by using monovalent My6-Fab' or reduced by using 
the soluble chymotryptic fragment of myosin, the actual effect 
of My6 binding was to increase the actin-activated ATPase 
activity of myosin. Thus none of the monoelonal antibodies 
compete with actin or nucleotides for binding to myosin. This 
is  not  surprising as the  actin  and  nucleotide  binding  sites 
probably represent the most conserved parts of the molecule 
whereas the antibodies all show considerable specificity for D. 
myosin and are therefore against sites on the myosin molecule 
that have been less conserved in evolution. 
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